0012015035

download 0012015035

of 5

Transcript of 0012015035

  • 7/25/2019 0012015035

    1/5

    Copyright2015 Korean Society of Otorhinolaryngology-Head and Neck Surgery177

    ,

    .1)

    , ,

    ,

    .

    , ,

    ,

    .,

    . 20

    (cervical vertigo),

    .2)

    BrandtBronstein3),

    (somatic nerve)

    The Diagnosis and Treatment of the Cervical VertigoJoo Young Kim, Wee Hwang Kim, Jang Soo Lee, Hyun Myung Oh,

    Dae Woong Kim, and Dong Jin Choi

    Department of Otolaryngology-Head and Neck Surgery, Kwangju Christian Hospital, Gwangju, Korea

    Received

    June 13, 2014

    Revised September 3, 2014

    Accepted September 8, 2014

    Address for correspondence

    Dong Jin Choi, MD

    Department of Otolaryngology-

    Head and Neck Surgery,

    Kwangju Christian Hospital,

    37 Yangnim-ro, Nam-gu,

    Gwangju 503-715, Korea

    Tel +82-62-650-5095

    Fax +82-62-650-5090

    E-mail [email protected]

    Background and ObjectivesZZVertigo is an illusion of environmental movement due to var-

    ious causes, thus it is hard for medical doctors to determine the exact kind of dizziness in the

    nal diagnosis. Recently, cervical vertigo was reported from several vertigo cases. Cervical ver-

    tigo is dened as sensation of rotation, resulting from an alteration of the neck proprioceptive

    afferents of the upper cervical spine. The aim of our study is to document the clinical features

    and the treatment outcomes in vertigo patients with myofascial pain syndrome(MPS).

    Subjects and MethodZZA total of 488 patients, excluding 18 patients who received other di-

    agnosis, were examined to investigate the reasons for dizziness. We evaluated 34 patients, who

    were diagnosed with cervical vertigo by questionnaire after MPS treatments. Clinical evalua-

    tions for cervical vertigo were performed on all subjects, and vestibular function tests were also

    performed in patients with vertigo symptoms. All patients received a total of 4 t reatments in-

    cluding trigger point injection, physical therapy or medication, and then followed up, respec-

    tively. The symptom changes of dizziness, patient satisfaction and cervical pain were checked

    before and treatment 1, 2, 4 times by Visual Analogue Scale(VAS)score.

    ResultsZZThere were signicant improvement in the VAS score of dizziness, patient satisfac-

    tion and cervical pain after treatment for MPS.

    ConclusionZZTreatment for MPS could improve dizziness in cervical vertigo with MPS pa-

    tients, but further study is needed to clearly conrm the cervical vertigo with MPS for improv-

    ing patients quality of life. Korean J Otorhinolaryngol-Head Neck Surg 2015;58(3):177-81

    Key WordsZZMyofacial pain syndromeTrigger pointVertigo.

    Otology Korean J Otorhinolaryngol-Head Neck Surg2015;58(3):177-81 / pISSN 2092-5859 / eISSN 2092-6529http://dx.doi.org/10.3342/kjorl-hns.2015.58.3.177

    onlineMLComm

  • 7/25/2019 0012015035

    2/5

    Korean J Otorhinolaryngol-Head Neck Surg2015;58(3):177-81

    178

    (myofascial pain syndrome, MPS)

    .

    ,

    MPS

    .

    , 2013312014228

    542(256,

    286).36506

    , 18

    488(245, 243)

    .

    ,

    , , ,

    , ,

    ,,,.,

    , , Dix-Hallpike, Romberg

    , tandem gait , ,

    , , , ,

    .

    .

    BrandtBronstein3),

    .

    TravellSimon4)(taut band)

    (tender spot)

    , (trig-

    ger pont injection, TPI)

    .5,6)

    ,

    (temporalis muscle), (sternocleido-

    mastoid muscle),(cervical paraspinatus

    muscle),(levator scapular muscle), (upper

    trapezius muscle) (Fig. 1),

    , .7)

    34

    (TPI)1

    24.

    (Lenox, 60 mg, Ildong Pharm, Seoul, Korea; 1

    3)(Mulex, 50 mg, Chodang Pharm, Seoul,

    Korea; 13)2

    .

    0.5% 5%

    , , ,

    .

    1, 2, 4

    Visual Analogue Scale(VAS)

    . 0

    , 10

    Fig. 1.Dermographic distribution of ve muscles arounding thehead, neck, and shoulders that were checked for myofascial triggerpoints.

    Temporalis muscle

    Sternocleidomastoid muscle

    Cervical paraspinal muscle

    Levator scapulae muscle

    Upper trapezius muscle

  • 7/25/2019 0012015035

    3/5

    Cervical Vertigo Kim JY, et al.

    www.jkorl.org179

    . VAS

    . 10

    0

    .VAS

    , 0, 10

    .

    SPSS 17.0

    (SPSS Inc., Chicago, IL, USA)Fishers exact

    test, , ,

    unpaired t-test.

    ,

    Wilcoxon signed rank test.

    95% (p-value0.05).

    268

    (54.9%), 98(20.1%), 58(11.9%),

    34(7.0%), 5(1.0%),

    3(0.6%), 22(4.5%)

    .

    121, 47, 43,

    15, 3, 1,

    13.

    147, 51, 19,

    16, 2, 2,

    9,

    (p0.05, by Fishers exacttest). , 4,

    3(Table 1).

    34(19,15

    ). 42.742.5, 43.4

    . .

    23.55.6(: 22.34.2, : 24.16.1),

    15.54.7(: 14.95.4,: 15.93.1).

    2.71.1(: 2.61.4, : 2.91.9).

    (p0.05, by unpaired t-test)(Table 2).

    ,

    1

    ,

    .

    1

    .1

    Table 2.Characteristics of cervical vertigo group

    Variables Cervical vertigo group

    Sex(M:F) 19:15

    Age(M:F) 42.7(42.5:43.4)*

    Symptom duration(days)

    (M:F)

    23.55.6(22.34.2:24.16.1)*

    Duration of treatment(days)

    (M:F)

    15.54.7(14.95.4:15.93.1)*

    Number of trigger points(M:F) 02.71.1(2.61.4:2.91.9)*

    *p0.05, by unpaired t-test. M:male, F:female

    Table 1.The distribution of nal diagnosis in dizziness 488 cases

    Disease Cases(male:female) %

    BPPV 268(147:121)* 54.9

    VN 098(51:47)* 20.1

    Menieres disease 058(15:43)* 11.9

    Cervical vertigo 034(19:15)* 07.0

    CVA 005(2:3)* 01.0

    Infectious disease 003(2:1)* 00.6

    Others 022(9:13)* 04.5

    *p0.05, by Fishers exact test. BPPV:benign paroxysmal posi-tional vertigo, VN:vestibular neuritis, CVA:cerebrovascularaccident

    Table 3.The comparison between pretreatment VAS score and posttreatment VAS score checked at 1, 2, and 4 times after treatmentfor vertigo, patients satisfaction and cervical pain (meanSD)

    VariablesVAS score

    Vertigo Patients satisfaction Cervical pain

    Pretreatment 8.461.30* 1.480.94* 7.841.51*

    Posttreatment(1st) 3.530.95* 7.511.51* 4.511.65*

    Posttreatment(2nd) 2.960.84* 8.140.48* 3.150.95*

    Posttreatment(4th) 1.941.15* 8.950.45* 2.861.12*

    *p0.05, by Wilcoxon signed rank test. VAS:Visual Analogue Scale, SD:standard deviation

  • 7/25/2019 0012015035

    4/5

    Korean J Otorhinolaryngol-Head Neck Surg2015;58(3):177-81

    180

    (p0.05, by Wilcoxon signed rank test)(Table 3).

    41.1%.

    33.4%. , ,

    13.6%, 8.5%, 3.4%(Table 4).

    , ,

    .8,9)

    .

    ,

    .

    . ,

    .

    ,

    , ,,

    , , ,

    ,

    .

    RyanCope10)

    , ,

    ,

    .

    ,

    ,

    , 3

    .11)

    .

    ,

    .12)

    ,

    ,

    (30~45%).4,13)

    5~40%.14)

    ,

    .

    , ,

    ,(41.1%, 33.4%)

    . Bracher 11)

    .

    .

    .7)

    ,

    .

    , Brandt-Bronstein

    (TPI),

    , 14, 1, 2

    , 4

    , ,

    .

    .

    ,

    ,

    .

    ,

    Table 4.Distribution of trigger points in neck and shoulder musclesfor patients with cervical vertigo with MPS

    Muscle Cervical vertigo group (%)

    Temporalis 03.4

    Sternocleidomastoid 08.5

    Cervical paraspinatus 33.4

    Upper trapezius 41.1

    Levater scapular 13.6

    MPS:myofascial pain syndrome

  • 7/25/2019 0012015035

    5/5

    Cervical Vertigo Kim JY, et al.

    www.jkorl.org181

    .

    REFERENCES

    1) Stone HE. Vertigo:a practical approach. Emerg Med Australas 2004;

    16(1):13-6.

    2) Wrisley DM, Sparto PJ, Whitney SL, Furman JM. Cervicogenic

    dizziness:a review of diagnosis and treatment. J Orthop Sports Phys

    Ther 2000;30(12):755-66.

    3) Brandt T, Bronstein AM. Cervical vertigo. J Neurol Neurosurg

    Psychiatry 2001;71(1):8-12.

    4) Travell DG, Simon SD. Myofascial pain and dysfunction. In:Simons

    DG, Travell JG, Simons LS, editors. Travell & Simons Myofascial

    Pain and Dysfunction:the Trigger Point Manual. 2nd ed. Baltimore:

    Williams & Wilkins;1999. p.12-93.

    5) Tough EA, White AR, Richards S, Campbell J. Variability of criteria

    used to diagnose myofascial trigger point pain syndrome--evidence

    from a review of the literature. Clin J Pain 2007;23(3):278-86.

    6) Myburgh C, Larsen AH, Hartvigsen J. A systematic, critical review

    of manual palpation for identifying myofascial trigger points:evidence

    and clinical signicance. Arch Phys Med Rehabil 2008;89(6):1169-76.

    7) Cho DK, Rhee CK, Lee SJ, Jang YY, Hyun JK. Myofascial pain

    syndrome in patients with cervical vertigo. J Korean Acad Rehabil

    Med 2011;35(2):243-9.

    8) Kim K, Hong YS, Cho HC, Cho HH, Jang CH, Cho YB. A clinical

    review of 1,060 dizziness cases who visited patients in emergency

    room. Korean J Otorhinolaryngol-Head Neck Surg 2009;52(4):302-6.

    9) Dieterich M. Dizziness. Neurologist 2004;10(3):154-64.

    10) Ryan GM, Cope S. Cervical vertigo. Lancet 1955;269(6905):1355-8.

    11) Bracher ES, Almeida CI, Almeida RR, Duprat AC, Bracher CB. A

    combined approach for the treatment of cervical vertigo. J Manipulative

    Physiol Ther 2000;23(2):96-100.

    12) Kentala E, Rauch SD. A practical assessment algorithm for diagnosis

    of dizziness. Otolaryngol Head Neck Surg 2003;128(1):54-9.

    13) Cummings M, Baldry P. Regional myofascial pain:diagnosis and

    management. Best Pract Res Clin Rheumatol 2007;21(2):367-87.

    14) Ramirez LM, Ballesteros LE, Sandoval GP. Topical review :

    temporomandibular disorders in an integral otic symptom model.

    Int J Audiol 2008;47(4):215-27.